02.12.2025
Prescription Digital Therapeutics
Podcast
Opportunities Abound for PDTs, with Click Therapeutics, Syneos Health Podcast
By Shaheen Lakhan, MD, PhD, FAAN
Chief Medical Officer
Where science meetssoftware.
Software as treatment.
Delivered to your phone.
Prescribed by your physician.
Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of software, creating a new way to treat disease.
Digital treatments, tangible outcomes.
We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs.
Click SE
Medicine just got a digital upgrade: Software-Enhanced Drugs™
Click SE™ solutions combine software with pharmacotherapy to create software-enhanced drug™ treatments, designed to deliver added clinical benefit to patients compared to drug alone.
One powerful platform. Many ways to treat disease.
Our multimodal, platform-based approach targets disease and drives outcomes from multiple different angles, combining scientifically proven therapies with proprietary neuromodulatory mechanisms of action to deliver clinically-meaningful interventions.
Latest at Click
Recent publications
Collaborators
By embracing collaborations that build on our unique areas of expertise, we’re powering a new era of medicine.
Contact
Join us in our journey to raise the bar of modern medicine with software as treatments.
Join usStay up to date with news and updates
Click Therapeutics Today
In numbers
Upcoming event
Apr30LSX World Congress Europe 2025
Integrating Digital Health & DTx Solutions into Pharma
Speaker:
David Benshoof Klein
Founder & CEO
Business Design Centre
London
Products Pipeline
Click Therapeutics Announces Series C, Dassault Systèmes and Medidata Make Strategic Investment
Dassault Systèmes announced a strategic investment in Click Therapeutics, having provided the entire Series C funding round, which closed earlier in March. The investment establishes a strong and future-forward partnership between Click Therapeutics and Dassault Systèmes’ Medidata Solutions designed to extend the patient experience beyond clinical trials to include digital therapeutics in the real world, enabling both enhanced long-term patient benefit and robust real-world data opportunities.
The expanded relationship between Click and Medidata will set a gold standard and unified offering for digital plus drug clinical trial design and execution, and provide a clear path to best-in-class Prescription Digital Therapeutics and Software-Enhanced Drugs™ product approvals for therapeutic innovators worldwide. Building upon Medidata’s existing customer base of over 2,300 life sciences clients, this partnership will both extend the reach of Click’s capabilities as well as the benefits of digital therapies to more patients.
In numbers
Upcoming event
Apr30LSX World Congress Europe 2025
Integrating Digital Health & DTx Solutions into Pharma
Speaker:
David Benshoof Klein
Founder & CEO
Business Design Centre
London
Products Pipeline
Click Therapeutics Announces Series C, Dassault Systèmes and Medidata Make Strategic Investment
Dassault Systèmes announced a strategic investment in Click Therapeutics, having provided the entire Series C funding round, which closed earlier in March. The investment establishes a strong and future-forward partnership between Click Therapeutics and Dassault Systèmes’ Medidata Solutions designed to extend the patient experience beyond clinical trials to include digital therapeutics in the real world, enabling both enhanced long-term patient benefit and robust real-world data opportunities.
The expanded relationship between Click and Medidata will set a gold standard and unified offering for digital plus drug clinical trial design and execution, and provide a clear path to best-in-class Prescription Digital Therapeutics and Software-Enhanced Drugs™ product approvals for therapeutic innovators worldwide. Building upon Medidata’s existing customer base of over 2,300 life sciences clients, this partnership will both extend the reach of Click’s capabilities as well as the benefits of digital therapies to more patients.